Advancements in Next-Generation Sequencing (NGS) and bioinformatics have given the microbiome field unprecedented insight into previously lesser understood microbial communities in and on the human body.
Through this insight, there has been a huge increase in R&D related to the skin microbiome and what impact this may have on skin health and disease. From pioneering academic research into various skin pathologies such as Psoriasis, Acne & Atopic Dermatitis to companies developing novel therapeutic and cosmetic products which seek to address patient and consumer needs.
CosmosID helps fuel this research through its CLIA/GLP facility, standardized workflows and industry-leading bioinformatics to generate unbiased sequencing data and strain-level resolution of bacteria, viruses, phages, fungi, protists, AMR & Virulence Factors.
Join CosmosID’s resident Molecular Biology expert, Dr Arne Materna, as he walks you through how to design and execute a skin microbiome study as well as showcase unseen strain-level insights into samples collected from Psoriasis patients.
A microbiologist & molecular biologist by training, Dr Materna received his doctoral degree from the University of Konstanz & his post-doc training at the Massachusetts Institute of Technology. Arne later joined Pacific Biosciences as systems architect of a new Next-generation Sequencing device. In 2012, Arne joined CLC bio, acquired by QIAGEN in 2013. Arne directed QIAGEN’s portfolio of bioinformatics solutions prior to joining CosmosID in 2018.
© 2021 CosmosID. All rights reserved